Press Releases

CHICAGO – Brinks Hofer Gilson & Lione, one of the largest intellectual property law firms in the U.S., has named Jay H. Reiziss and Laura A. Lydigsen co-chairs of the firm’s Appellate practice and William R. Boudreaux and Jeff Nichols co-chairs of its Biotechnology & Pharmaceutical practice.

"Mr. Reiziss, Ms. Lydigsen, Mr. Nichols and Mr. Boudreaux not only provide our clients with superior representation as individual attorneys, but have also demonstrated outstanding leadership ability,” said Brinks president Gary M. Ropski. “Each is an asset to their respective practice group, and most importantly, to the clients that Brinks represents.”

Jay H. Reiziss, a shareholder in Brinks' Washington D.C. office, is an international trade attorney with experience in the biotechnology, chemical, and computer hardware and software industries. A former attorney at the U.S. International Trade Commission (ITC), Mr. Reiziss has extensive experience leading Section 337 investigations, as well as anti-dumping, countervailing duty and safeguards investigations. His practice encompasses all aspects of litigation before the ITC, as well as matters before the U.S. Court of Appeals for the Federal Circuit. He also has an active practice in investigations before the U.S. Department of Commerce, the U.S. Trade Representative (USTR), U.S. Customs and Border Protection and the Federal courts. Mr. Reiziss holds a J.D. from American University and a B.A. from Rutgers University.

Laura A. Lydigsen has been an attorney in Brinks' Chicago office for six years. She focuses her practice on intellectual property litigation and prosecution at both the appellate and district court levels for cases in the biotechnology, pharmaceutical and medical devices industries, including patent infringement cases brought under the Hatch-Waxman Act. Before joining Brinks, she served as a law clerk to the Hon. Alvin A. Schall of the U.S. Court of Appeals for the Federal Circuit and to the Hon. Ruben Castillo of the U.S. District Court for the Northern District of Illinois. Ms. Lydigsen holds a J.D. from Washington University School of Law in St. Louis and a B.A. in biological sciences and French cultural studies from Wellesley College.

William R. Boudreaux, a shareholder in Brinks' Ann Arbor office, provides counsel to pharmaceutical companies throughout the entire product development process, from research and development to marketing and post-launch product management. Mr. Boudreaux assists clients with global patent portfolio creation, legal opinions and product lifecycle planning. His experience also includes Hatch-Waxman litigation strategy and support, transactional work, appellate brief writing and international patent procurement and enforcement. Prior to joining Brinks, Mr. Boudreaux was senior in-house counsel for Pfizer. He holds a J.D. from the Paul M. Hebert Law Center at Louisiana State University and a B.S. in biochemistry, also from Louisiana State University.

Jeff Nichols, a shareholder in Brinks’ Chicago office, focuses his intellectual property law practice on patent litigation with an emphasis on the biotechnology and pharmaceutical industries. His experience includes first-chair trial responsibilities, Markman hearings, summary judgment hearings and managing the discovery process from start to finish. In addition, he has served as the principal attorney for several appeals to the U.S. Court of Appeals for the Federal Circuit. Mr. Nichols holds a J.D., with honors, from the University of Connecticut School Of Law and a B.S. in chemistry from Truman State University.

Brinks Hofer Gilson & Lione is one of the largest intellectual property law firms in the United States and serves the intellectual property needs of clients around the world. Brinks has 150 attorneys, scientific advisors and patent agents who specialize in intellectual property litigation and all aspects of patent, trademark and copyright law. The firm also advises on issues relating to intellectual asset management, trade secret, unfair competition, and technology and licensing agreements. Brinks routinely handles assignments for companies in the electrical, chemical, and mechanical engineering sectors; the biotechnology, pharmaceutical and nanotechnology industries; and for companies whose work relates to Internet and computer technology law. The firm’s trademark practice works on behalf of clients who deal in a wide variety of products and services. Brinks is based in Chicago and has offices in Ann Arbor, Mich., Indianapolis, Ind., Research Triangle Park, N.C., Salt Lake City, Utah, and Washington, DC. More information is available at www.usebrinks.com.